Novartis AG (ADR) (NYSE:NVS)

CAPS Rating: 5 out of 5

Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products.

Recs

0
Player Avatar utri (< 20) Submitted: 7/1/2011 11:44:37 AM : Outperform Start Price: $58.61 NVS Score: -10.57

Has exposure to both patented and generic medicine.Good balance sheet.Should move up after Alcon acquisition is complete.

Featured Broker Partners


Advertisement